URGENT UPDATE on Refuse-to-Receive Guidance, Revision 1, Issues for Generic Drugs
Since my post yesterday, a number of readers pointed out that the DMF assessment requirement as a basis for Refuse-to-Receive file determination has been removed from the previous guidance. I concur that is the case, and there are and may be multiple reasons for its removal.